These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4897003)

  • 21. [Role of thymus epithelial tissue in the formation of natural immune tolerance].
    Beletskaia LV; Gnezditskaia EV
    Usp Sovrem Biol; 1975; 79(1):128-37. PubMed ID: 1092082
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrathymic pathogenesis and dual genetic control of myasthenia gravis.
    Wekerle H; Ketelsen UP
    Lancet; 1977 Mar; 1(8013):678-80. PubMed ID: 66477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.
    VAN DER GELD H; FELTKAMP TE; VAN LOGHEM J; OOSTERHUIS HJ; BIEMOND A
    Lancet; 1963 Aug; 2(7304):373-5. PubMed ID: 14044286
    [No Abstract]   [Full Text] [Related]  

  • 24. [Morphologic changes in the thymus gland in myasthenia under the effect of radiation therapy].
    Kop'eva TN
    Arkh Patol; 1968; 30(7):13-9. PubMed ID: 5727112
    [No Abstract]   [Full Text] [Related]  

  • 25. [Myasthenia gravis. Immunologic aspects].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):819-21. PubMed ID: 4103765
    [No Abstract]   [Full Text] [Related]  

  • 26. An investigation of experimental myasthenia gravis.
    Jones SF; Brennan JL; McLeod JG
    J Neurol Neurosurg Psychiatry; 1971 Aug; 34(4):399-403. PubMed ID: 4328884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editorial: "Myasthenia gravis" or the autoimmunity, thymic disease, neuromuscular block poser.
    Goldstein G
    West J Med; 1975 Aug; 123(2):138-9. PubMed ID: 170746
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.
    Houseley J; Oppenheim JJ
    Br Med J; 1967 Jun; 2(5553):679-81. PubMed ID: 6024528
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental autoimmune myasthenia gravis induced by thymic acetylcholine receptor-like protein.
    Kawanami S; Mori S
    Fukuoka Igaku Zasshi; 1994 Apr; 85(4):120-7. PubMed ID: 8200609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
    Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
    Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymic germinal centres in myasthenia gravis: a correlative study.
    Goldstein G
    Clin Exp Immunol; 1967 Jan; 2(1):103-7. PubMed ID: 6030793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.
    Aharonov A; Tarrab-Hazdai R; Abramsky O; Fuchs S
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1456-9. PubMed ID: 1055418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle pathology, thymoma, and immunological abnormalities in patients with myasthenia gravis.
    Oosterhuis HJ; Bethlem J; Feltkamp TE
    J Neurol Neurosurg Psychiatry; 1968 Oct; 31(5):460-3. PubMed ID: 4885252
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental myasthenia].
    Kamińska A; Mrozek K; Rafalowska J
    Neuropatol Pol; 1977; 15(1):153-62. PubMed ID: 840386
    [No Abstract]   [Full Text] [Related]  

  • 36. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 37. Thymic lymphoid follicles in autoimmune diseases. II. Histological, histochemical and electron microscopic studies.
    Tamaoki N; Habu S; Kameya T
    Keio J Med; 1971 May; 20(1):57-68. PubMed ID: 5148022
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiology and immunological profile of myasthenia gravis and its subgroups.
    Romi F; Hong Y; Gilhus NE
    Curr Opin Immunol; 2017 Dec; 49():9-13. PubMed ID: 28780294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinico-immunological characteristics of myasthenia patients].
    Shevniuk MM; Shumilina ES; Dubov AM
    Lik Sprava; 1996; (7-9):81-3. PubMed ID: 9072276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contribution to pathohistology of the extrinsic ocular muscles in myasthenia gravis pseudoparalytica (author's transl)].
    Remus I; Lahl R
    Klin Monbl Augenheilkd; 1974 Jun; 164(6):776-83. PubMed ID: 4138873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.